2 results
Approved WMOCompleted
to determine the normal FGF23 response in case of hypophosphatemia
Approved WMOCompleted
The objective of this investigation is to describe visual outcomes and assess the safety at 12 months (330 - 420 days) post bilateral implantation of the AcrySof® IQ PanOptix* Presbyopia correcting IOL Model TFNT00.